Twitter Beğeni Hilesi

As September begins, we would like to announce that we're officially moving to LinkedIn and closing this account. We're immensely thankful for all the wonderful connections we've made here! Keep up with us on LinkedIn, following National Cancer Institute, & subscribing to our Linkage newsletter.

HAPPENING TOMORROW: Tune in at 9:00AM EST ⏰ for the 168th Meeting of the National Cancer Advisory Board (NCAB) where Dr. Kimryn Rathmell will deliver her Director's report. videocast.nih.gov/watch=55097

Here’s an award that might be the perfect fit if you’re a new investigator ready to start your independent career in #DataScience: datascience.cancer.gov/news-events/ne… NIH

"This book breaks down something that we don't often think about—why don't we know what we don't know?" - Dr. Kimryn Rathmell cancerletter.com/book-review/20…

Follow the Division of Cancer Epidemiology & Genetics on LinkedIn: go.nih.gov/DCEGLinkedIn

In 2017, we awarded $90m to 4 teams to take on our first round of #CancerGrandChallenges. In the 7 years that followed, they made incredible progress, changing ways of thinking and paving the way for future research. Learn more on our new impact hub 👇 cancergrandchallenges.org/impact

RASopathies are a group of rare syndromes caused by changes in genes involved in the Ras/MAPK cell signaling pathway. These syndromes may raise a person's risk of certain types of cancer, often in childhood. Learn more about the RASopathies Study. go.nih.gov/3WYKoeo #CCAM

From the Cancer Prevention Science Blog: "An Improved #ProstateCancer Biomarker Test May Help Men Avoid Unnecessary Biopsy." NCI-supported researchers validated the test through the NCI Early Detection Research Network. go.nih.gov/G8BysrD #ProstateCancerAwarenessMonth

The proper management of data is critical for advances in biomedical and cancer research. NCI's Division of Cancer Biology provides information and guidance about the NIH Data Management and Sharing policy to researchers. Learn more. go.nih.gov/fIXktN5

Register to learn more about the Molecular Characterization Initiative (MCI) and Childhood Cancer Data Initiative. The MCI aims to facilitate comprehensive clinical and #molecular characterization of #ChildhoodCancers at no cost to participants. datascience.cancer.gov/news-events/ev…

Mark your calendar! The next Global Cancer Research and Control Seminar is October 10 at 10AM ET. Professor Jennifer Moodley will discuss breast and #CervicalCancer prevention in Southern Africa. Register today. go.nih.gov/iyTKuqy #NCIGlobal #CancerResearch

It's easier than ever to search, find, save, and share cancer control research #FundingOpportunities from NCI. Start your search here ⤵️ go.nih.gov/JTMrkJ0 #CancerControl #CancerResearch

Death rates from uterine cancer have been rising in the United States, and are highest among non-Hispanic Black women, according to a 2022 study led by NCI’s Dr. Megan Clarke. Learn more. go.nih.gov/HTqKOXL #GynecologicCancerAwareness

The Annual Plan & Budget Proposal proposes funding to increase investments in research grants, train the cancer workforce, modernize and expand clinical studies infrastructure, and explore ways to prevent or intercept cancer. go.nih.gov/5COjOLp #NCIFuture #CancerResearch

Attention researchers: The Childhood Cancer Clinical Data Commons is an open-access web application with harmonized #ChildhoodCancer demographics and phenotypic clinical data. go.nih.gov/XR4KFUl #Data4ChildhoodCancer

Are you interested in the latest in #CancerPrevention? Sign up to receive timely, informative emails from NCI's Division of Cancer Prevention with research news; funding announcements and deadlines; training information; and more! go.nih.gov/XXKTWnu

Investigators supported by the NCI Division of Cancer Biology share how their fundamental scientific discoveries led to important breakthroughs in #CancerResearch. go.nih.gov/y3o910P #Every1HasARole

Cameron was 8 years-old when he was diagnosed with brain cancer. But because of expanded access to molecular testing, his care team identified the treatment most likely to work against his specific type of #medulloblastoma. go.nih.gov/wmcjhy4 #CCAM #Data4ChildhoodCancer